ライフサイエンスコーパス: bis-

1 F (-0.821) > AOCS (-0.798) > AOAC (-0.795) > BIS (-0.754).

2 The P2X(7) antagonists 1-[N,O-bis (1,5-isoquinolinesulfonyl)-N-methyl-l-tyrosyl]-4-pip

3 of a ditopic ligand, which consists of a 2,6-bis-(1'-methylbenzimidazolyl)-4-oxypyridine moiety attac

4 Bis-(1,1-dioxoperhydro-1,2,4-thiadiazinyl-4)methane (tau

5 arbonylbis(imino-3,1-phenylenecarbonylamino)]bis-(1,3,5-naphthalen etrisulfonic acid), 6Na (NF023), 8

6 measured using the dyes propidium iodide and bis-(1,3-dibutylbarbituric acid) trimethine oxonol to de

7 is indicated by the potential-sensitive dye bis-(1,3-dibutylbarbituric acid)pentamethine oxonol.

8 the distance of the binding site for diTBA (bis-(1,3-diethylthiobarbituric acid)trimethine oxonol),

9 f the first members of a new family of spiro-bis-(1,9-diamino-substituted-phenalenyl)boron neutral ra

10 quadruplex targeting fluorophore (BMVC, 3, 6-bis-(1-methyl-4-vinylpyridinium)-carbazole diiodide) and

11 or glasses prepared from indomethacin or 1,3-bis-(1-naphthyl)-5-(2-naphthyl)benzene, stability is opt

12 *2H2O 4, CMCR.2bpeh*benzil*ethanol 5 (bpeh = bis-(1-pyridin-4-yl-ethylidene)-hydrazine), and CECR*2bp

13 t in self-assembled films of the derivative, bis-[1-(10-decyl)-4-[2-(4-dimethylaminonaphthalen-1-yl)-

14 Moreover, topical application of Bis (100 microM) once daily for 9 d to the freshly depil

15 ed by plasmid DNA and the redox-active lipid bis-(11-ferrocenylundecyl)dimethylammonium bromide (BFDM

16 e mono-(13)C ((13)C identical with(12)C) and bis-(13)C ((13)C identical with(13)C) labeled alkyne iso

17 determine 18O/16O ratios for 5',3'-guanosine bis-[18O1]phosphate and TM[18O1]P with precisions of app

18 '-ethynyl-(2,2';6',2''-terpyridinyl))-10,2 0-bis (2',6'-bis(3,3-dimethyl-1-butyloxy)phenyl)porphinato

19 yl) ether [BADGE.HCl.H(2)O], and bisphenol A bis (2,3-dihydroxypropyl) ether [BADGE.2H(2)O], using hi

20 lhexyl 2,3,4,5-tretabromophalate (TBPH), 1,2-bis (2,4,6-tribromophenoxy) ethane (BTBPE), and decabrom

21 preincubated with acetoxymethyl ester of 1,2-bis (2-amino-phenoxy) ethane N:, N:, N:, N:-tetra-acetic

22 PK inhibitors 1, 4-diamino-2, 3-dicyano-1, 4-bis (2-aminophenylthio) butadiene (UO126; for ERK1/2), t

23 fluorescent pH indicator (pyranin or [2',7'-bis (2-carboxyethyl)-5(6)-carboxyfluorescein] [BCECF]) w

24 ed greater resistance to cell killing by 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) than overexpres

25 1-chloro, 2,4-dinitrobenzene (CDNB); or 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU).

26 The fraction of naturally produced bis (2-ethylhexyl) phthalate (DEHP), a ubiquitous plasti

27 lyzed for the presence of bisphenol A (BPA), bis (2-ethylhexyl) phthalate (DEHP), nonylphenol monoeth

28 c monoketone analog of curcumin, termed 3, 5-bis (2-flurobenzylidene) piperidin-4-one (EF24), has bee

29 ors were immersed in pH indicator or glyoxal bis (2-hydro-xyanil) (GBHA).

30 Systemically administered N,N'-bis (2-hydroxybenzyl) ethylenediamine-N,N'-diacetic acid

31 i-beta-glucan monoclonal antibody, using 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) c

32 s and Candida parapsilosis by using XTT [2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) c

33 queous and dried coffee rings of 5-5'-Dithio-bis (2-nitrobenzoic acid) (DTNB) solutions were examined

34 bation of BLMVECs with the GR inhibitor, 1,3 bis-(2 chloroethyl)-1-nitrosourea, abolished the inhibit

35 minal positions with acrylodan and ruthenium bis-(2,2'-bipyridyl)-1,10-phenanthroline-9-isothiocyanat

36 s three large slowly reversible antagonists, bis-(2,2,6,6-tetramethyl-4-piperidinyl) sebacate (BTMPS)

37 sed free N-heterocyclic carbenes (NHCs), 1,3-bis-(2,4,6-trimethylphenyl)imidazol-2-ylidene (IMes) and

38 are contrasted with the case of the related bis-(2,5-di-tert-butylphenyl)perylenetetracarboxylic dii

39 Reaction of bis-(2,6-diisopropylphenyl)-imidazol-2-ylidene borane wi

40 thylphenyl)imidazol-2-ylidene (IMes) and 1,3-bis-(2,6-diisopropylphenyl)imidazol-2-ylidene (IPr), and

41 Treatment with an agonist of CAR, 1,4-bis-(2-(3,5-dichloropyridoxyl))benzene, potentiated CAR-

42 ting agents cyclopiazonic acid (CPA) and 1,2-bis-(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (B

43 1,2-Bis-(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-ac

44 c initiator (R)- or (S)-1,1'-binaphthyl-2,2'-bis-(2-bromoisobutyrate).

45 eno[3,4-b]thiophenyl]-2,2'-dicarboxylic acid bis-(2-butyloctyl) ester (BTT) and 4,8-bis(2-butyloctyl)

46 -) in a stopped-flow fluorometer using 2',7'-bis-(2-carboxyethyl)-5-(and -6)-carboxyfluorescein (BCEC

47 H-sensitive fluorescent indicator dye 2', 7'-bis-(2-carboxyethyl)-5-(and -6)carboxyfluorescein (BCECF

48 one of the following: acetoxymethyl of 2',7'-bis-(2-carboxyethyl)-5-(and 6)-carboxyfluorescein (BCECF

49 related with a rise in pH indicated by 2',7'-Bis-(2-Carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF

50 The fluorophore used is 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF

51 using the pH-sensitive fluorescent dye 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF

52 ed by the pH-sensitive fluorescent dye 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF

53 de-field fluorescence microscopy with 1',7'- bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF

54 tive cantilever biosensor and a probe, 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein acetox

55 The chemical pH-indicator 2,7-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein corrob

56 by using the cytoplasmic pH indicator 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein-acetox

57 with intrabacterial pH measured using 2',7'-bis-(2-carboxyethyl)-5-carboxyfluorescein and compared t

58 EK) on exposure to the DNA-damaging compound bis-(2-chloroethyl) sulfide.

59 Additional cycles of chemotherapy using 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) resulted in sim

60 Bis-(2-ethylhexyl) tetrabromophthalate (TBPH) is widely

61 Poly[{2,5-bis-(2-ethylhexyl)-3,6-bis-(thien-2-yl)-pyrrolo[3,4-c]py

62 ndgap donor-acceptor copolymer poly[2,6-(4,4-bis-(2-ethylhexyl)-4H-cyclopenta[2,1-b;3,4-b']-dithiophe

63 DP was detected from 0.26 to 11 pg m(-3) and bis-(2-ethylhexyl)-tetrabromophthalate (TBPH) ranged fro

64 2-[(2-[[Bis-(2-ethylsulfanylethyl)amine]methyl]phenylamine)methy

65 2-[11-[(2-[[Bis-(2-ethylsulfanylethyl)amino]methyl]phenylamino)methy

66 1,3-Bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) i

67 mino]-nicotinic acid [PD307243 (PD)] and 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea [NS1643 (N

68 d by cross-linking with a novel reagent, 1,2-bis-(2-iodoethoxy) ethane, and quaternization with iodom

69 The crystal and molecular structure of the bis-(2-MeImH) complex shows the macrocycle to be in a sa

70 ent of the eight methylene resonances of the bis-(2-MeImH) complex to the four ethyl groups was possi

71 R spectrum of this complex, like that of the bis-(2-MeImH) complex, is of the "large g(max)" type, wi

72 A as compared to 1.974 A) than those of the bis-(2-MeImH) complex.

73 anthroline (CuP) or the bifunctional reagent bis-(2-methanethiosulfonatoethyl)amine hydrochloride (bi

74 s blocked by the oxidizing agent 5,5'-dithio-bis-(2-nitrobenzoic acid) (DTNB) and the T channel antag

75 ors while the oxidizing reagent 5, 5'-dithio-bis-(2-nitrobenzoic acid) (DTNB) caused inhibition.

76 A continuous, 5,5'-dithio-bis-(2-nitrobenzoic acid) (DTNB)-based assay for the CBS

77 sulfite value by standard DTNB (5,5'-dithio-bis-(2-nitrobenzoic acid)) method and the present method

78 2] (1) and [(TPA)Fe(OTf)2] (2) [BPMEN = N,N'-bis-(2-pyridylmethyl)-N,N'-dimethyl-1,2-ethylenediamine;

79 itogens phenobarbital (PB) and TCPOBOP (1, 4-bis [2-(3, 5-dichloropyridyloxy)] benzene).

80 TCBOPOP (1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene) an agonist of

81 ED-CC and TATE-PEG2-HBED-CC (HBED-CC is N,N'-bis [2-hydroxy-5(carboxyethyl)benzyl] ethylenediamine-N,

82 nthesis and conformational properties of 2,6-bis-[2-((4S)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl)phenyl

83 -N-4-(1-azi-2,2,2-trifluoroethyl)benzoyl-1,3-bis-[2-(3)H] (D-mannose-4-yloxy)-2-propylamine exofacial

84 Long-term exposure to 1,4-Bis-[2-(3,5-dichloropyridyloxy)] benzene yielded profoun

85 effect on the response to the xenobiotic1,4-Bis-[2-(3,5-dichloropyridyloxy)] benzene.

86 xposed to the mouse-specific CAR ligand, 1,4-bis-[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP).

87 tor (CAR) ligands phenobarbital (PB) and 1,4-bis-[2-(3,5-dichloropyridyloxy)]benzene, and of acetamin

88 (68)Ga-PSMA-(N,N'-bis-[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,

89 Most notable was NSC 95397 (2,3-bis-[2-hydroxyethylsulfanyl]-[1,4]naphthoquinone), which

90 crine and the bis-pyridinium derivative 4,4'-bis-[(2,6-dichloro-benzyloxy-imino)-methyl]-1,1'-propane

91 With 4-methyl-cis-2-pentene, both bis- (22) and monoadduct (23) were isolated, the former

92 These are called bis- (3, 6, 9, 12) and monoadducts (4, 7, 10, 13).

93 Trp-Pro was shown to have high 2,2'-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) radical scav

94 ,5,5'-tetramethylbenzidine (TMB), 2,2'-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid), dopamine, a

95 ), P3HT, and the liquid-crystalline poly(2,5-bis (3-tetradecylthiophen-2-yl)thieno[3,2-b]thiophene),

96 olecular-scale packing structure of poly(2,5-bis (3-tetradecylthiophene-2-yl)thieno[3,2-b]thiophene)

97 Bis-(3',5') cyclic di-guanylate (c-di-GMP) is a key bact

98 formation in vitro and pathogenesis in vivo--bis-(3',5')-cyclic dimeric GMP (c-di-GMP), flagella, and

99 High cellular concentrations of bis-(3',5')-cyclic dimeric guanosine mono-phosphate (c-d

100 dentified as an inner membrane protein whose bis-(3',5')-cyclic dimeric guanosine monophosphate (c-di

101 colony morphogenesis by modulating levels of bis-(3',5')-cyclic-dimeric-guanosine (c-di-GMP), a secon

102 Bis-(3',5')-cyclic-dimeric-guanosine monophosphate (c-di

103 c binding protein NspS and the transmembrane bis-(3'-5') cyclic diguanosine monophosphate (c-di-GMP)

104 ity to form and degrade the second messenger bis-(3'-5') cyclic dimeric GMP (c-di-GMP).

105 Bacterial bis-(3'-5') cyclic GMP (cyclic di-GMP [c-di-GMP]) serves

106 pertussis, synthesizes the second messenger bis-(3'-5')-cyclic diguanosine monophosphate (c-di-GMP)

107 Alterations in bis-(3'-5')-cyclic dimeric GMP (c-di-GMP) levels have be

108 e of cellular levels of the second messenger bis-(3'-5')-cyclic dimeric GMP (c-di-GMP) was identified

109 Bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di

110 acterial second messenger signaling molecule bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di

111 The bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di

112 The bacterial second messenger bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di

113 FimX has phosphodiesterase activity towards bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di

114 Bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di

115 regulated receptor for the second messenger--bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di

116 The second messenger bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di

117 intracellular secondary messenger c-di-GMP (Bis-(3'-5')-cyclic dimeric guanosine monophosphate), to

118 rts suggested the bacterial second messenger bis-(3'-5')-cyclic-dimeric-guanosine monophosphate (c-di

119 1,1-Bis-(3'-indolyl)-1-(p-substitutedphenyl)methanes contain

120 gap polymer (bandgap <1.4 eV), poly[2,7-(5,5-bis-(3,7-dimethyloctyl)-5H-dithieno[3,2-b:2',3'-d]pyran)

121 hydroxyl radical trapping reagent 2,2'-azino-bis-(3-ethyl-benz-thiazoline-6-sulfonic acid) (ABTS) and

122 picrylhydrazyl radical (DPPH) and 2,2'-azino-bis-(3-ethylbenzo-thiazoline-6-sulfonic acid) diammonium

123 ion to scavenge both the cationic 2,2'-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS(+)) r

124 laccase-catalyzed reaction using 2, 2-Azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) as a

125 3 at pH 2.5 and 70 degrees C with 2,2'-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid) used as a su

126 isease (AD), we have synthesized 1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (5, BSB).

127 luorescent probe (trans, trans),-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB) tha

128 veloped a probe, [(trans,trans)-1-bromo-2, 5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB)], a

129 ing the binding of [(125)I]E,E-6, 1-iodo-2,5-bis-(3-hydroxycarbonyl-4-methoxy)styrylbenzene (IMSB) to

130 Treatment with 2,6-Bis-(3-methoxy-4-propoxy-benzylidene)-cyclohexanone (BM2

131 r post-ischemia treatment with 40 mg/kg of N-bis-(3-phenyl-propyl)9-oxo-fluorene-2,7-diamide, a novel

132 ne N-oxide (DMPO), tyrosine, and 2, 2'-azino-bis-[3-ethylbenzothiazoline]-6-sulfonic acid (ABTS).

133 Compared to vehicle alone, Bis (300 microM), applied twice daily to paired sites fo

134 e) and the ERbeta selective agonist DPN (2,3-bis (4-hydroxyphenyl) propionitrile) alone and in combin

135 synthesized by solvothermal reaction of 1,4-bis-(4-(3,5-dicyano-2,6-dipyridyl)dihydropyridyl)benzene

136 nalysis shows that SOF-7 comprises 2 and 1,4-bis-(4-(3,5-dicyano-2,6-dipyridyl)pyridyl)benzene (3); t

137 groups as donor connected to a fluorene, 2,7-bis-(4-(N,N-diphenylamino)phen-1-yl)-9,9'-dimethylfluore

138 ylfluorene (1), or spirobifluorene core, 2,7-bis-(4-(N,N-diphenylamino)phen-1-yl)-9,9'-spirobifluoren

139 carries the fluorescent diamidine DB99 (2,5-bis-(4-amidinophenyl)-3,4-dimethylfuran) into trypanosom

140 g the eight chalcone derivatives tested, 3,5-bis-(4-boronic acid-benzylidene)-1-methyl-piperidin-4-on

141 emical series exemplified by N-[5-(1-{3-[2,2-bis-(4-fluoro-phenyl)-acetylamino]-propyl}-piperidin-4-y

142 a HIF-1alpha knockout cell line and 3-[2-[4-(bis-(4-fluorophenyl) methylene]-1-piperidinyl)ethyl]-2,3

143 diphenylmethyl]-1H-pyrazole), senicapoc (2,2-bis-(4-fluorophenyl)-2-phenylacetamide), and NS6180 (4-[

144 and E isomers of the lithium enolate of 1,3-bis-(4-fluorophenyl)-2-propanone (5F-Li) show divergent

145 inistering dopamine reuptake inhibitor 1-(2-[bis-(4-fluorophenyl)methoxy]ethyl)- 4-(3-phenylpropyl)pi

146 Within the series, 3-[2-[bis-(4-fluorophenyl)methoxy]ethylidene]-8-methyl-8-azabi

147 ium channel blocker, LY393615 ((N-Butyl-[5,5-bis-(4-fluorophenyl)tetrahydrofuran-2-yl]methylamine hyd

148 Curcumin, 1,7-bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,6-diene-3,5-dio

149 ovides evidence that the ERbeta agonist, 2,3-bis-(4-hydroxy-phenyl)-propionitrile (DPN), and the sele

150 hyperpolarizable chromophores, based on N,N- bis-(4-methoxyphenyl) aryl-amino donors and phenyl-trifl

151 on-withdrawing ability, e.g., diphenylamino, bis-(4-methoxyphenyl)amine, nitro, and benzothiazole, we

152 with organic fluors (diphenyloxazole and 1,4-bis-(4-methyl-5-phenyl-2-oxazolyl)benzene) and an extrac

153 The crystal and molecular structure of the bis-(4-NMe(2)Py) complex also shows the macrocycle to be

154 MS) cleavable cross-linker (containing a 1,3-bis-(4-oxo-butyl)-urea group, BuUrBu) generating charact

155 phenanthrene derivatives, 3,6-diphenyl-9,10-bis-(4-tert-butylphenyl)phenanthrene (TphP, T1), 3,6-di(

156 aphenylporphinato]zinc(II))-6-[(5"-10'',20''-bis [4-(3-methoxy-3-methylbutoxy)phenyl]porphinato)zinc(

157 Here, we report a novel bis-[4Fe-4S] cluster binding protein, DSD-Fdm, in which

158 rt inhibitor 100microM 2,2'-(1,2-ethenediyl) bis (5-isothiocyanatobenzenesulfonic acid).

159 ated by increased binding of the fluorophore bis-(5, 5')-8-anilino-1-naphthalene sulfonic acid to the

160 an, 3.17 muM for triclocarban, 0.372 muM for bis-(5-chloro-2-hydroxyphenyl)methane, 4.89 muM for 2-ch

161 The conversion of 1,3-bis-(6-amino-pyridin-2-yl)-urea (1) with N,N'-carbonyldi

162 A library of bis-(6-chloro-2-methoxy-acridin-9-yl) and bis-(7-chloro-

163 -propyl]-piperazin-1-yl]-propyl)-amine, N,N'-bis-(6-chloro-2-methoxy-acridin-9-yl)-1,8-diamino-3,6-di

164 Ni]ClO4.CH3OH (1, bppppa- = monoanion of N,N-bis-[(6-phenyl-2-pyridyl)methyl]-N-[(6-pivaloylamido-2-p

165 d bis-phenyl-C61 -butyric acid methyl ester (bis-[60]PCBM) isomer mixture by preparative peak-recycli

166 of bis-(6-chloro-2-methoxy-acridin-9-yl) and bis-(7-chloro-2-methoxy-benzo[b][1,5]naphthyridin-10-yl)

167 ycles using the p-channel semiconductor 5,5'-bis-(7-dodecyl-9H-fluoren-2-yl)-2,2'-bithiophene (DDFTTF

168 on (NLF) contains the pentapeptide mimic 1,4-Bis (9-O dihydroquinidinyl) phthalazine/hydroquinidine 1

169 structure for the complex of the bisacridine bis-(9-aminooctyl(2-(dimethylaminoethyl)acridine-4-carbo

170 ',6'-diyl)bis(iminomethylene-2 ,1-phenylene)]bis-(9CI), a rhodamine-derived bisboronic acid (RhoBo) d

171 In this study, N,N'-bis (acetyl acetone) ethylenediimine (Fe3O4@SiO2-EDN) wa

172 Association constants of a bis-(acetylguanidinium)ferrocene dication to various (di

173 th phthalate and maleate carboxylates to the bis-(acetylguanidinium)ferrocene salt in pure water.

174 The tethered bis-(alkynylcarbene) complex Cp(CO)(2)Re=C(Tol)C(triple

175 orward practical synthetic approaches to 3,4-bis- and 3,4,5-tris(trifluoromethyl)pyrazoles have been

176 anols 15 and 16and their transformation into bis- and mixed-onium chlorofumarates 19, 20ab, and 26.

177 Comparison of the bis- and monoacridine spermine motifs (8 and 17) reveale

178 In both bis- and monoadducts of acyclic alkenes, the configurati

179 Bis- and monoadducts were obtained also in additions of

180 ion followed by global deprotection afforded bis- and monophosphorylated hexaacylated Lipid A mimetic

181 rategy for the oDMS structures by which both bis- and monosubstituted oDMS derivatives up to 59 Si-at

182 Novel bis- and tetraepoxides and bicyclic acetal products, ari

183 ion dictates the formation of uranium mono-, bis- and tris(imido) products.

184 howed excellent activity in the synthesis of bis- and tris-1,4-substituted 1,2,3-triazoles.

185 so indicate that the triaroylbenzene-derived bis- and tris-crown ethers do not engage in intramolecul

186 s for convergent synthesis of highly complex bis- and tris-diazene intermediates.

187 oether conjugates parallels the formation of bis- and tris-glutathionyl conjugates of hydroquinone, w

188 Additionally, bis- and tris-homoallylic alcohols are oxidized to provi

189 ansfer can give either mono- or bis-NHCs, or bis- and tris-NHCs.

190 y conventional or microwave heating and that bis- and tris-primary alcohols are also processed effici

191 um energy equilibrium geometries of explicit bis- and tris-solvated contact ion pairs (CIPs) and tetr

192 luated using three selected series of mono-, bis-, and tris-adducted fullerene materials.

193 y (BP86) calculations of 1syn and its mono-, bis-, and tris-Ag(I) complexes suggested that the coordi

194 S-CC-MgBr) leads to a distribution of mono-, bis-, and tris-alkynylated iron(II)-SciOPP species due t

195 ipyridyl)dihydropyridyl)benzene (1) and 5,5'-bis-(azanediyl)-oxalyl-diisophthalic acid (2).

196 containing a cleavable disulfide; (2) 2',2''-bis-(AzC12)-CL with two of the four fatty acid tails of

197 CTTTTGCAAAAG)(2)and its 2:1 complex with the bis -benzimidazole Hoechst 33258 has been investigated b

198 from a monomer unit, which consists of a 2,6-bis-(benzimidazolyl)-4-hydroxypyridine unit attached to

199 ctivity of the enzyme, while ethylene glycol-bis (beta-aminoethyl ether) N,N,N',N'-tetraacetic acid (

200 Ca(2+) and calcium chelator ethylene glycol-bis (beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (

201 Many biological systems use ethylene glycol bis (beta-aminoethylether)-N,N,N',N'-tetraacetic acid (E

202 Trifluoperazine, W7, or ethylene glycol-bis-(beta-aminoethyl ether)-N,N'-tetraacetic acid (EGTA)

203 ments, the effect of calcium, ethyleneglycol-bis-(beta-aminoethyl ether)-N-N' -tetraacetic acid (EGTA

204 ion of the calcium chelator, ethylene-glycol-bis-(beta-aminoethylether)-N,N,N',N'-tetraacetic acid, g

205 tly treated with 1 millimolar ethyleneglycol-bis-[beta-aminoethylether]-N,N,N',N'-tetraacetic acid [E

206 S)-N,N'-bis-(phenylsulfonyl)-, and (2S)-N,N'-bis-(Boc)-3-(2-pyrrolyl)alanines (10, 3, and 14, respect

207 se whose activity is restricted to tris- and bis-, but not mono-phosphorylated phosphatidylinositol p

208 ,4'''-[carbonyl-bis[imino-5,1,3-benzenetriyl-bis-(carbonylimino)]] tetrakis-benzene-1,3-disulfonic ac

209 ing intracellular pH measurements with 2',7'-bis-(carboxyethyl)-5(6)-carboxyfluorescein (BCECF).

210 n monitored with the pH-sensitive dye 2', 7'-bis-(carboxyethyl)-5(6)-carboxyfluorescein (BCECF).

211 +) using the H(+)-sensitive dye BCECF [2',7'-bis-(carboxyethyl)-5-(and-6)-carboxyfluorescein] in wide

212 The IL-COOH was further modified with N,N'-bis (carboxymethyl)-l-lysine hydrate to bind copper ions

213 The fluorescent probe rhodamine 110 bis-(CBZ-L-isoleucyl-L-prolyl-L-arginine amide) dihydroc

214 ethylhexyl) adipate (DEHA)), and one FR (2,2-bis (chloromethyl)-propane-1,3-diyltetrakis(2-chloroethy

215 A novel acetylenic tricyclic bis-(cyano enone), TBE-31, is a lead compound in a serie

216 )H](1-azi-2,2,2,-trifluoroethyl)benzoxyl-1,3-bis-(d-mannos-4-yloxy l)-2-propylamine ([(3)H]ATB-BMPA)

217 BF4] (1-3, X = I, Br, and Cl; (t)BuPNP = 2,6-bis-(di-tert-butylphosphinomethyl)pyridine) with coordin

218 1,5-Bis-(dihexyl-N-nitrosoamino)-2,4-dinitrobenzene (C6') an

219 ') and an inactive form of the compound [1,5-bis-(dihexylamino)-2,4-dinitrobenzene (C6)] were tested

220 ydrocaffeoyl) spermine (0.2-1.7), N(1),N(10)-bis-(dihydrocaffeoyl) spermidine (1.1-2.6), and N(1),N(5

221 -2.5), sinapoyl hexose (0.1-1.8), N(1),N(14)-bis-(dihydrocaffeoyl) spermine (0.2-1.7), N(1),N(10)-bis

222 (99m)Tc-[bis (dimethoxypropylphosphinoethyl)-ethoxyethylamine (PN

223 divergent agents gallamine and hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide (W

224 xy)phenyl]vinyl}-anthracene (A-P6d, 3), 9,10-bis-[(E)-(p-{(E)-[m,p-bis(hexyloxy)phenyl]vinyl}phenyl)v

225 e (BTZT-P6t, 7), and two arylvinylenes, 9,10-bis-{(E)-[m,p-bis(hexyloxy)phenyl]vinyl}-anthracene (A-P

226 oxic metabolite of hydroquinone, and 2-bromo-bis-(glutathion-S-yl)hydroquinone, another cytotoxic qui

227 or two DEB-specific DNA-DNA cross-links, 1,4-bis-(guan-7-yl)-2,3-butanediol (bis-N7G-BD) and 1-(guan-

228 guanine monoadducts, which can then form 1,4-bis-(guan-7-yl)-2,3-butanediol (bis-N7G-BD) lesions.

229 ify DEB-induced DNA-DNA conjugates, e.g. 1,4-bis-(guan-7-yl)-2,3-butanediol (bis-N7G-BD), 1-(guan-7-y

230 yl-fluoroornitithine) and MGBG [methylgloxal-bis (guanyl hydrazone)].

231 te (ethanamine-2,2'-(hydroxynitrosohydrazone)bis-) had no effect on a chloramphenicol acetyltransfera

232 ependence of the UV-vis spectrum of the cis-(bis-(imidazole))ruthenium(III) unit.

233 tention of configuration, of conversion of a bis- into a monoadduct, and of opening of a monoadduct a

234 Presumably, the bis- inverted question mark6, 6 closed adducts are forme

235 (5a, 5b) and a new type of monoadduct with a bis- inverted question mark6, 6 closed structure (4a, 4b

236 ed question mark6, 6-closed monoadduct and a bis- inverted question mark6,6 closed adduct.

237 Deep anesthesia (BIS < 45) during the intraoperative period is associated

238 sonable binding modes of 2'-MANT-3'-dATP and bis-(M)ANT-nucleotides at sGC alpha1beta1 require a 3'-e

239 }phenyl)ethynyl]-anthracene (PA-P6t, 2), 4,7-bis-{[m,p-bis(hexyloxy)phenyl]ethynyl}-2,1,3-benzothiadi

240 series of five extended arylacetylenes, 9,10-bis-{[m,p-bis(hexyloxy)phenyl]ethynyl}-anthracene (A-P6t

241 reparation of epidithio-, epitetrathio-, and bis-(methylthio)diketopiperazines from diketopiperazines

242 her than those observed for (64)Cu-di-acetyl-bis (N(4)-methylthiosemicarbazone) and approach those of

243 er medications, acamprosate (Campral-calcium-bis (N-acetylhomotaurinate)) is clinically used in many

244 pylphosphinoethyl)-ethoxyethylamine (PNP5)]-[bis (N-ethoxyethyl)-dithiocarbamato (DBODC)] nitride (N-

245 All bis-(N,N-dialkylanilino) donor-substituted push-pull tri

246 e chelating bis-N-heterocyclic carbene (NHC) bis-(N-Dipp-imidazole-2-ylidene)methylene (abbreviated {

247 Complete spectral assignments for the bis-(N-MeIm) and -(4-NMe(2)Py) complexes have been made

248 evious work has shown that certain steroidal bis-(N-phenyl)ureas, derived from cholic acid, form crys

249 nd chelation of intracellular calcium by 1,2-bis (o-Aminophenoxy) ethane-N,N,N',N'-tetraacetic acid t

250 including 2-amino-ethoxydiphenylborate, 1,2-bis (o-aminophenoxy) ethane-tretraacetic acid (acetoxyme

251 psigargin when clamping [Ca(2+)](i) with 1,2-bis (o-Aminophenoxy)ethane-N,N,N',N'tetraacetic acid tet

252 TPEN), a specific zinc chelator, but not 1,2-bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid (

253 rsed with the cell-permeable Ca(2+) chelator bis-(O-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid t

254 with GABA in the absence or presence of 1,2-bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid,

255 ition or by preloading the cells with BAPTA (bis-(o-aminophenoxy)-N,N'N'-tetraacetic acid).

256 Furthermore, BAPTA [bis-(o-aminophenoxy)ethane-N,N',N'-tetraacetic acid], a

257 he cytosolic Ca(2+) chelator, 5, 5'-dimethyl-bis-(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (5

258 s metabolism of NAADP by chelating Ca2+ with bis-(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (B

259 780, and the intracellular Ca2+ chelator 1,2-bis-(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (B

260 ibited by the calcium chelator 5,5'-dimethyl-bis-(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (d

261 treatment of the cells with Ca(2+) chelator bis-(O-aminophenoxyl)ethane-N,N,N',N'-tetraaceticacid- a

262 n pyridine leads to the isolation of [Co(I)2(bis-(OMe)salophen)Na2Py4][Na(cryptand)]2, 8.

263 A family of p-cyclophanes based on bis- or tetrafunctionalized 1,4-bisthiophenol units link

264 eaction intermediate, 2 Schiff bases, and 28 bis- or tris(pyrazol-3(4)-yl)methane ligands.

265 of Mfp-2 and iron, which interact by forming bis- or tris-DOPA-iron complexes.

266 eptanone at ca. -23 degrees C to give mono-, bis-, or tris-diazeniumdiolate (-N2O2(-)) products: pota

267 S100beta improved discriminations based on BIS (p = 0.0008), and BIS improved discriminations based

268 lorinated biphenyl (PCB)-153; 1-dichloro-2,2-bis (p-chlorophenyl) ethylene (p,p'-DDE), and hexachloro

269 gstD1 encodes a 1,1,1-trichloro-2,2-bis-(P-chlorophenyl)ethane dehydrochlorinase; gstD21, a

270 detected elevated levels of 1,1-dichloro-2,2-bis-(p-chorophenyl)ethylene and organophosphate metaboli

271 Pretreatment of cp70 cells with bis-(p-nitrophenyl) phosphate, an esterase inhibitor, be

272 A bis-(p-nitrophenyl)ureidodecalin shows especially promis

273 )phenyl]ethynyl}-anthracene (A-P6t, 1), 9,10-bis-[(p-{[m,p-bis(hexyloxy) phenyl]ethynyl}phenyl)ethyny

274 (2S)-N-(Boc)-N'-(Phenylsulfonyl)-, (2S)-N,N'-bis-(phenylsulfonyl)-, and (2S)-N,N'-bis-(Boc)-3-(2-pyrr

275 nitude difference in photoreactivity between bis- (photo-DIBOD, 1) and mono-cyclopropenone-caged dibe

276 ed lysis but did not reduce lysis induced by bis (pivaloyloxymethyl) (E)-4-hydroxy-3-methyl-but-2-eny

277 MBPP) or a synthetic cell-permeable prodrug, bis (pivaloyloxymethyl) (E)-4-hydroxy-3-methyl-but-2-eny

278 nzyloxy-imino)-methyl]-1,1'-propane-1,3-diyl-bis -pyridinium dibromide (Duo3), which, in contrast to

279 enzoic acid, and QZ2, 2-[6-hydroxy-3-oxo-4,5-bis-(quinolin-8-ylaminomethyl)-3H-xanthen-9-yl]benz oic

280 idazolium cation, and pKa = 21.2 for the 1,3-bis-((S)-1-phenylethyl)benzimidazolium cation.

281 in the presence of Zn (II)-N,N'-o-phenylene bis (salicylideneimine) ternary complex wherein Zn (II)

282 oss-linking agent Sulfo-EGS (ethylene glycol bis (sulfosuccinimidylsuccinate)).

283 7,13-diylbis(5-methoxy-6,12-benzof urandiyl)]bis-, tetrakis[(acetyloxy)methyl] ester-detected [Na(+)]

284 The approach is concise and, for the bis-(THF) pair, capitalizes on the full retention of con

285 Poly[{2,5-bis-(2-ethylhexyl)-3,6-bis-(thien-2-yl)-pyrrolo[3,4-c]pyrrole-1,4-diyl} -co-{2,

286 In addition, bis-, tri-, and up to octaadducts of Sc3N@C80 were detec

287 Bis-[tri-(3,5-di-tert-butyl)phenylmethyl]-peroxide 2 was

288 Small amounts of trans-1,2-cyclohexadiyl bis-(trifluoroacetate) also form.

289 The freed 5-ClUra is derivatized with 3, 5-bis-(trifluoromethyl)-benzyl bromide, which is detected

290 cting bacteriopurpurin methyl ester with 3,5-bis-(trifluoromethyl)benzylamine, produced promising pho

291 3,5-Bis-(trifluoromethyl)phenyl isothiocyanate, was used as

292 n fragment from dissociative loss of the 3,5-bis-(trifluoromethyl)phenylmethyl moiety: m/z 215, 289,

293 Bis (trifluoromethylsulfonyl)imide (NTf2) anion of ionic

294 ionic liquid (IL)1-buthyl-methylpyrolydinium bis (trifluromethyl sulfonyl) imide [C(4)mpyr][NTf(2)].

295 -5 pentacene), and 2,2,10,10-tetraethyl-6,14-bis-(triisopropylsilylethynyl)-1,3,9,11-tetraoxa-dicycl

296 ilylethynyl)pentacene (TIPS pentacene), 6,14-bis-(triisopropylsilylethynyl)-1,3,9,11-tetraoxa-dicyclo

297 h the use of the bridged polysilsesquioxane, bis-(trimethoxysilylethyl)benzene (BTEB), as the princip

298 QSAR investigations of a series of 53 novel bis-, tris-, and tetrakis(carboxylato)platinum(IV) compl

299 A series of mono-, bis-, tris-, and tetrakis(porphinato)zinc(II) (PZn)-elab

300 Bis-, tris-, and tetrakisuracil-substituted 12-, 13-, 17